Total Payments
$122,567
2024 Payments
$19,975
Companies
12
Transactions
134
Medicare Patients
586
Medicare Billing
$32,644
Payment Breakdown by Category
Consulting$83,234 (67.9%)
Other$30,413 (24.8%)
Travel$5,819 (4.7%)
Food & Beverage$3,102 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $83,234 | 40 | 67.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,144 | 5 | 9.9% |
| Honoraria | $10,269 | 5 | 8.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,000 | 2 | 6.5% |
| Travel and Lodging | $5,819 | 22 | 4.7% |
| Food and Beverage | $3,102 | 60 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $72,426 | 80 | $0 (2024) |
| Blueprint Medicines Corporation | $9,518 | 5 | $0 (2024) |
| CTI BioPharma Corp. | $9,187 | 15 | $0 (2023) |
| ABBVIE INC. | $7,948 | 9 | $0 (2024) |
| Celgene Corporation | $5,846 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $5,446 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $5,044 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $4,270 | 1 | $0 (2023) |
| MorphoSys, US Inc. | $2,600 | 1 | $0 (2023) |
| Eli Lilly and Company | $148.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,975 | 12 | Incyte Corporation ($8,563) |
| 2023 | $23,213 | 20 | CTI BioPharma Corp. ($8,363) |
| 2022 | $13,561 | 21 | Incyte Corporation ($8,654) |
| 2021 | $10,065 | 7 | Incyte Corporation ($5,265) |
| 2020 | $23,478 | 10 | Incyte Corporation ($16,165) |
| 2019 | $17,974 | 24 | Incyte Corporation ($12,050) |
| 2018 | $4,104 | 17 | Incyte Corporation ($3,969) |
| 2017 | $10,198 | 23 | Incyte Corporation ($10,198) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $7,192.50 | General |
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,865.00 | General |
| 09/03/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $45.00 | General |
| 09/03/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| 07/08/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 05/20/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,012.50 | General |
| 05/13/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| 04/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $92.77 | General |
| Category: ONCOLOGY | ||||||
| 01/15/2024 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $2,156.00 | General |
| 01/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $337.50 | General |
| 01/09/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 12/21/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $240.00 | General |
| 12/07/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $106.62 | General |
| 12/07/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 11/15/2023 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| 11/14/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| 11/07/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $2,643.19 | General |
| 10/19/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $122.78 | General |
| Category: Hematology | ||||||
| 09/12/2023 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $49.02 | General |
| 07/06/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Hematology | ||||||
| 06/02/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Hematology | ||||||
| 05/10/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| 05/04/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| 04/16/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 127 | 211 | $27,322 | $6,940 |
| 2022 | 6 | 170 | 277 | $44,869 | $10,296 |
| 2021 | 9 | 179 | 263 | $45,176 | $10,185 |
| 2020 | 4 | 110 | 178 | $22,929 | $5,224 |
Total Patients
586
Total Services
929
Medicare Billing
$32,644
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 38 | $8,968 | $3,376 | 37.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 15 | $9,000 | $1,482 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 121 | $3,993 | $1,016 | 25.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 18 | $4,050 | $853.74 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 19 | $1,311 | $212.04 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 48 | $11,328 | $4,619 | 40.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 26 | 34 | $19,244 | $3,731 | 19.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 15 | 19 | $4,275 | $900.65 | 21.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 16 | 31 | $4,185 | $382.96 | 9.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 55 | 115 | $3,767 | $340.47 | 9.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 30 | $2,070 | $321.23 | 15.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 23 | 25 | $14,150 | $2,934 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 27 | $6,332 | $2,493 | 39.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $7,520 | $1,837 | 24.4% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 12 | 18 | $5,742 | $1,174 | 20.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 12 | 12 | $2,700 | $699.84 | 25.9% |
| 36430 | Transfusion of blood or blood products | Office | 2021 | 12 | 13 | $3,055 | $387.27 | 12.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 53 | 116 | $3,596 | $348.00 | 9.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 23 | 24 | $1,656 | $274.06 | 16.5% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2021 | 12 | 17 | $425.00 | $37.66 | 8.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 35 | $7,980 | $2,888 | 36.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 13 | 14 | $7,924 | $1,575 | 19.9% |
| 36430 | Transfusion of blood or blood products | Office | 2020 | 15 | 15 | $3,525 | $420.55 | 11.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 53 | 114 | $3,500 | $339.66 | 9.7% |
About Dr. Stephen Oh, MD
Dr. Stephen Oh, MD is a Hematology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841494358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Oh, MD has received a total of $122,567 in payments from pharmaceutical and medical device companies, with $19,975 received in 2024. These payments were reported across 134 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($83,234).
As a Medicare-enrolled provider, Oh has provided services to 586 Medicare beneficiaries, totaling 929 services with total Medicare billing of $32,644. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Saint Louis, MO
- Active Since 06/11/2007
- Last Updated 04/17/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1841494358
Products in Payments
- JAKAFI (Drug) $22,059
- Vonjo (Drug) $9,187
- AYVAKIT (Drug) $4,973
- PEMAZYRE (Drug) $1,845
- VENCLEXTA (Drug) $1,198
- Epclusa (Drug) $100.22
- OJJAARA (Drug) $92.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Saint Louis
Dr. Elaine Majerus, Md, MD
Hematology — Payments: $132,201
Hematology $132,201
Dr. Amy Zhou, Md, MD
Hematology — Payments: $64,851
Hematology $64,851
Dr. Govind Bhagat
Hematology — Payments: $52,064
Hematology $52,064
Dr. Kristen Sanfilippo, Md, MD
Hematology — Payments: $15,043
Hematology $15,043
Dr. Gregory Longmore, Md, MD
Hematology — Payments: $9,342
Hematology $9,342
Dr. Rudolph Yanuck, M.d, M.D
Hematology — Payments: $5,679
Hematology $5,679